Muromonab-CD3 Biosimilar - Research Grade

Muromonab-CD3 Biosimilar - Research Grade, Mouse IgG2a CH1+Human IgG1 CH2+CH3-Mouse Kappa

Target: CD3e.

Specificity: Detects human CD3 epsilon OKT-3. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Muromonab.

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background: Muromonab is an immunosuppressant drug given to reduce acute rejection in patients with organ transplants. It is a monoclonal antibody targeted at the CD3 receptor, a membrane protein on the surface of T cells. It was the first monoclonal antibody to be approved for clinical use in humans.

Concentration: 5mg/ml.

Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.

Purity: >95% by SDS-PAGE.

Endotoxin: ≤ 1.0 EU/mg as determined by the LAL method.

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.

• SKU: ICH5024-100MG
• Manufacturer: Ichorbio
• Manufacturer SKU: ICH5024-100MG
• Package Unit: 100mg
• Quantity Unit: STK
• Reactivity: Human
• Clonality: Monoclonal
• Application: Functional Assay
• Isotype: Mouse IgG2a CH1+Human IgG1 CH2+CH3-Mouse Kappa